Inventor · disambiguated record
Majid Mehtali
Also filed as: MEHTALI MAJID
35 granted patents·12 pending applications·846 citations·filing 1994–2021
98Inventor score
Top patents by PatentIndex Score
47 records- 0199US6492169B1Complementing cell linesCRUCELL HOLLAND BV·Filed 2000·Granted Dec 10, 2002·113 cites·7 claims
- 0297US6974695B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2001·Granted Dec 13, 2005·85 cites·22 claims
- 0396US6869794B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2002·Granted Mar 22, 2005·47 cites·13 claims
- 0495US6040174ADefective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 1994·Granted Mar 21, 2000·212 cites·19 claims
- 0591US7344883B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2005·Granted Mar 18, 2008·11 cites·15 claims
- 0689US7256036B2Modified adenoviral fiber and target adenovirusesTRANSGENE·Filed 2003·Granted Aug 14, 2007·24 cites·25 claims
- 0789US6350575B1Helper viruses for the preparation of recombinant viral vectorsTRANSGENE SA·Filed 2000·Granted Feb 26, 2002·25 cites·34 claims
- 0888US10160797B2Antibodies against Clostridium difficile toxins and methods of using the sameSANOFI PASTEUR BIOLOGICS LLC·Filed 2014·Granted Dec 25, 2018·8 cites·28 claims
- 0988US8148132B2Production of viral vaccines in suspension on avian embryonic derived stem cell linesMEHTALI MAJID·Filed 2006·Granted Apr 3, 2012·11 cites·26 claims
- 1084US6204060B1Viral vectors and line for gene therapyTRANSGENE SA·Filed 1996·Granted Mar 20, 2001·66 cites·42 claims
- 1184US6133028ADefective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 1999·Granted Oct 17, 2000·74 cites·33 claims
- 1282US9228205B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2014·Granted Jan 5, 2016·1 cites·15 claims
- 1382US7250293B2Complementing cell linesCRUCELL HOLLAND BV·Filed 2002·Granted Jul 31, 2007·4 cites·17 claims
- 1481US9040296B2Production of viral vaccines in suspension on avian embryonic derived stem cell linesMEHTALI MAJID·Filed 2012·Granted May 26, 2015·4 cites·13 claims
- 1580US6740511B1Modified adenoviral fibre and uses thereofTRANSGENE SA·Filed 2000·Granted May 25, 2004·10 cites·5 claims
- 1676US6569677B1Modified adenoviral fiber and target adenovirusesTRANSGENE SA·Filed 1998·Granted May 27, 2003·34 cites·10 claims
- 1774US7067309B2Defective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 2000·Granted Jun 27, 2006·2 cites·4 claims
- 1874US7005277B2Defective adenoviruses and corresponding complementation linesTRANSGENE SA·Filed 2000·Granted Feb 28, 2006·2 cites·8 claims
- 1972US8962311B2Method of obtaining chicken embryonic stem cellsVALARCHE ISABELLE·Filed 2007·Granted Feb 24, 2015·4 cites·11 claims
- 2072US6960469B2Adenoviral vectors encoding an antibody fused to a CD4 extracellular domainTRANSGENE SA·Filed 2001·Granted Nov 1, 2005·2 cites·10 claims
- 2171US12116402B2Antibodies against clostridium difficile toxins and methods of using the sameSANOFI PASTEUR INC·Filed 2021·Granted Oct 15, 2024·0 cites·4 claims
- 2269US9260694B2Generation of duck cell linesVALNEVA·Filed 2013·Granted Feb 16, 2016·2 cites·11 claims
- 2367US6475480B1Use of adenoviral E4 reading frames to improve expression of a gene of interestTRANSGENE SA·Filed 1999·Granted Nov 5, 2002·25 cites·52 claims
- 2466US2008199433A1Complementing cell linesCRUCELL HOLLAND BV·Filed 2007·Application pending·0 cites
- 2565US5889175ANucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replicationTRANSGENE SA·Filed 1994·Granted Mar 30, 1999·20 cites·11 claims
- 2663US7482155B1Chimeric promoters for controlling expression in smooth muscle cellsTRANSGENE SA·Filed 2001·Granted Jan 27, 2009·1 cites·16 claims
- 2762US11220537B2Antibodies against Clostridium difficile toxins and methods of using the sameSANOFI PASTEUR BIOLOGICS LLC·Filed 2018·Granted Jan 11, 2022·0 cites·19 claims
- 2861US6399587B1Recombinant adenoviral vectors comprising a splicing sequenceTRANSGENE SA·Filed 1998·Granted Jun 4, 2002·17 cites·13 claims
- 2956US2010062489A1Duck embryonic derived stem cell lines for the production of viral vaccinesVIVALIS·Filed 2008·Application pending·0 cites
- 3055US9701945B2Production of viral vaccines in suspension on avian embryonic derived stem cell linesVALNEVA·Filed 2015·Granted Jul 11, 2017·0 cites·22 claims
- 3153US2004038205A1Modified adenoviral fiber and usesTRANSGENE SA·Filed 2003·Application pending·0 cites
- 3252US2006140920A1Adenoviral vectors encoding an antibody fused to a CD4 extracellular domainTRANSGENE SA·Filed 2005·Application pending·0 cites
- 3352US2002072120A1Helper viruses for the preparation of recombinant viral vectorsFiled 2001·Application pending·0 cites
- 3451US2015225695A1Method of obtaining chicken embryonic stem cellsVALNEVA·Filed 2014·Application pending·0 cites
- 3551US2018135026A1Duck embryonic derived stem cell lines for the production of viral vaccinesVALNEVA·Filed 2017·Application pending·0 cites
- 3650US6066478AHelper viruses for preparing recombinant viral vectorsTRANSGENE SA·Filed 1996·Granted May 23, 2000·6 cites·24 claims
- 3749US9822345B2Method of making a virus using duck embryonic derived stem cell linesVALNEVA·Filed 2016·Granted Nov 21, 2017·0 cites·18 claims
- 3849US6479290B1Chimeric adenoviral vectorsTRANSGENE SA·Filed 1999·Granted Nov 12, 2002·8 cites·35 claims
- 3949US6228369B1Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effectTRANSGENE SA·Filed 1998·Granted May 8, 2001·9 cites·3 claims
- 4048US2010226912A1RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLSVIVALIS·Filed 2008·Application pending·0 cites
- 4146US2003157063A1Gene therapy using anti-gp41 antibody and CD4 immunoadhesinFiled 2001·Application pending·0 cites
- 4244US6284252B1Transdominant TAT variants of the human immunodeficiency virusTRANSGENE SA·Filed 1998·Granted Sep 4, 2001·9 cites·24 claims
- 4343US9182408B2Method of screening by using conformation sensitive peptidesMEHTALI MAJID·Filed 2005·Granted Nov 10, 2015·0 cites·22 claims
- 4442US2014287402A1Method for screening cellsGARRONE PIERRE·Filed 2012·Application pending·0 cites
- 4542US2011251085A1In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said proteinVIVALIS·Filed 2009·Application pending·0 cites
- 4641US5981258AComposition of trans-dominant variants of viral proteins for obtaining an antiviral effectTRANSGENE SA·Filed 1994·Granted Nov 9, 1999·10 cites·10 claims
- 4741US2003203488A1Viral vectors and line for gene therapyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Majid Mehtali files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →